Testing a combined flu and COVID-19 mRNA vaccine in older adults
Part of Infections, Lungs & breathing clinical trials.
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 65 and 85 years old.
- You are generally healthy or have stable medical conditions that are well-managed.
- You have not had the flu or COVID-19 in the past 3 to 6 months.
- You have not had a serious allergic reaction to any flu or COVID-19 vaccine before.
- You have not received a flu or COVID-19 vaccine recently (within the past 3 to 6 months).
- You do not have a weakened immune system or a history of certain heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new flu vaccine in adults aged 65 and older to see how well it prevents the flu. If you are generally healthy or manage chronic conditions well, you may be able to join.
This study tests a new combination vaccine that protects against both flu and COVID-19. It could be a convenient way for older adults to get two important vaccines in one shot.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
This study tests a new flu vaccine to see how well it protects adults aged 18 to 64. If you join, you'll get the vaccine and have some check-ups to see how your body responds.
This study tests a new investigational flu vaccine (FluMos-v2) with or without an adjuvant (ALFQ) to see how safe, tolerable, and effective it is. It may help protect against multiple flu strains.
This trial is testing a new mRNA-based flu vaccine in healthy adults. It aims to see if the vaccine is safe and effective at preventing influenza.
Hear when a new Influenza, Human+COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.